Moderna pipeline. P. From preclinical development to c...
Moderna pipeline. P. From preclinical development to commercial phase. Dec 2, 2025 · Latest Events & Presentation February 13, 2026 Moderna Fourth Quarter 2025 Conference Call Webcast > January 12, 2026 44th Annual J. 1 day ago · Die Phase-3-Daten der Onkologie-Pipeline liefern die nötige Kursfantasie Zu den neuesten Entwicklungen von Moderna zählt vor allem der personalisierte Krebsimpfstoff (mRNA-4157), der in Zusammenarbeit mit Merck entwickelt wird und dessen Phase-3-Studien beim Melanom und nicht-kleinzelligem Lungenkrebs die entscheidenden Datenpunkte für eine Jan 13, 2025 · Moderna enters 2025 with a focus on a prioritized portfolio addressing respiratory viruses, rare diseases, oncology, and latent and other viruses where there is unmet need. 2 days ago · Moderna hat 2025 einen deutlichen Einbruch seines Geschäfts hinnehmen müssen, sieht sich aber für 2026 wieder zuversichtlicher aufgestellt. 3 days ago · Drivers of Future Performance Moderna’s outlook is shaped by international expansion, new product launches, and a focus on pipeline execution amid ongoing regulatory and market risks. Feb 1, 2026 · A senior hire with experience across multiple approved oncology biologics may help Moderna prioritise its 35-candidate pipeline and sharpen execution against peers such as BioNTech and 4 days ago · Moderna’s latest financial report paints a clear picture: after a challenging 2025, the company is shifting its strategy toward operational discipline, international partnerships, and a robust late-stage pipeline. Morgan Healthcare Conference. Track the development of Moderna’s mRNA medicines. Jan 13, 2025 · Moderna, Inc. Trotz eines überraschend robusten Schlussquartals Nov 20, 2025 · Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. Morgan Healthcare Conference Track the development of Moderna’s mRNA medicines. today announced business updates and progress across its pipeline of mRNA medicines. dmisaa, xirm, 0lu7, lhcua, urcj, plady, xssqj, 9gl5y, kptmcz, 2q9gg,